Advertisement

ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies

Francesca Zammarchi, Simon Corbett, Lauren Adams, Peter C. Tyrer, Konstantinos Kiakos, Narinder Janghra, Teresa Marafioti, Charles E. Britten, Carin E.G. Havenith, Simon Chivers, Francois D'Hooge, David G. Williams, Arnaud Tiberghien, Philip W. Howard, John A Hartley and Patrick H. van Berkel

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted October 27, 2017
  • Accepted December 21, 2017
  • Published online January 3, 2018.


Contributors 
  • Francesca Zammarchi, 1 ADC Therapeutics (UK) Limited, London, United Kingdom;
  • Simon Corbett, 2 Cancer Research UK Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom;
  • Lauren Adams, 3 Spirogen/Medimmune Ltd, London, United Kingdom;
  • Peter C. Tyrer, 3 Spirogen/Medimmune Ltd, London, United Kingdom;
  • Konstantinos Kiakos, 2 Cancer Research UK Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom;
  • Narinder Janghra, 4 Department of Pathology, UCL Cancer Institute, London, United Kingdom
  • Teresa Marafioti, 4 Department of Pathology, UCL Cancer Institute, London, United Kingdom
  • Charles E. Britten, 1 ADC Therapeutics (UK) Limited, London, United Kingdom;
  • Carin E.G. Havenith, 1 ADC Therapeutics (UK) Limited, London, United Kingdom;
  • Simon Chivers, 1 ADC Therapeutics (UK) Limited, London, United Kingdom;
  • Francois D'Hooge, 3 Spirogen/Medimmune Ltd, London, United Kingdom;
  • David G. Williams, 3 Spirogen/Medimmune Ltd, London, United Kingdom;
  • Arnaud Tiberghien, 3 Spirogen/Medimmune Ltd, London, United Kingdom;
  • Philip W. Howard, 3 Spirogen/Medimmune Ltd, London, United Kingdom;
  • John A Hartley, 2 Cancer Research UK Drug DNA Interactions Research Group, UCL Cancer Institute, London, United Kingdom;
  • Patrick H. van Berkel, 1 ADC Therapeutics (UK) Limited, London, United Kingdom;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output